US Patent 8377446 Serum resistance factors of gram positive bacteria
Patent 8377446 was granted and assigned to Novartis on February, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 16, 2011
Date of Patent
February 19, 2013
Patent Application Number
13327882
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8377446 Serum resistance factors of gram positive bacteria
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
